{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:06:52Z","timestamp":1771459612033,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112735","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T19:30:40Z","timestamp":1722022240000},"page":"112735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Anti-mCD20 in combination with \u03b1-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia A mice"],"prefix":"10.1016","volume":"139","author":[{"given":"Qiaoyun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kehan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qizhen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112735_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.intimp.2024.112735_b0010","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","article-title":"A Randomized trial of factor VIII and neutralizing antibodies in hemophilia A","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112735_b0015","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/hae.14381","article-title":"Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update","volume":"27","author":"Hart","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.intimp.2024.112735_b0020","doi-asserted-by":"crossref","first-page":"1019275","DOI":"10.3389\/fimmu.2022.1019275","article-title":"Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications","volume":"13","author":"Luo","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030574","article-title":"The oncogenic lipid sphingosine-1-phosphate impedes the phagocytosis of tumor cells by M1 macrophages in diffuse large B Cell lymphoma","volume":"16","author":"Perry","year":"2024","journal-title":"Cancers (basel)."},{"key":"10.1016\/j.intimp.2024.112735_b0030","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/S2352-3026(23)00345-9","article-title":"Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b\/2 study","volume":"11","author":"Abrisqueta","year":"2024","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.intimp.2024.112735_b0035","series-title":"Drugs targeting CD20 in multiple sclerosis: pharmacology","author":"Carlson","year":"2024"},{"key":"10.1016\/j.intimp.2024.112735_b0040","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bjh.19147","article-title":"Frequency and outcomes of obinutuzumab-induced thrombocytopenia","volume":"203","author":"Ng","year":"2023","journal-title":"Br J Haematol."},{"key":"10.1016\/j.intimp.2024.112735_b0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1160\/TH14-01-0078","article-title":"Rituximab for treatment of inhibitors in haemophilia A","volume":"112","author":"Leissinger","year":"2014","journal-title":"A Phase II Study, Thrombosis & Haemostasis."},{"key":"10.1016\/j.intimp.2024.112735_b0050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/jth.14740","article-title":"Combined anti-CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors","volume":"18","author":"Doshi","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2024.112735_b0055","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1182\/blood-2010-06-293324","article-title":"Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice","volume":"117","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112735_b0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1160\/TH16-05-0404","article-title":"Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin","volume":"117","author":"Biswas","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.intimp.2024.112735_b0065","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3389\/fimmu.2020.01293","article-title":"B Cell depletion eliminates FVIII memory B Cells and enhances AAV8-coF8 Immune tolerance induction when combined with rapamycin","volume":"11","author":"Biswas","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0070","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ni.1789","article-title":"Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation","volume":"10","author":"van de Pavert","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0075","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0092-8674(00)81798-5","article-title":"A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen","volume":"87","author":"Forster","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112735_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172649","article-title":"The CXCL13\/CXCR5 immune axis in health and disease-implications for intrathecal B Cell activities in neuroinflammation","volume":"11","author":"Harrer","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.intimp.2024.112735_b0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2016.01.015","article-title":"Early BAFF receptor blockade mitigates murine Sj\u00f6gren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction","volume":"164","author":"Sharma","year":"2016","journal-title":"Clin Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.763065","article-title":"CXCL13 neutralization attenuates neuropsychiatric manifestations in lupus-prone mice","volume":"12","author":"Huang","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0095","article-title":"Association of platelet desialylation and circulating follicular helper T Cells in patients with thrombocytopenia","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0100","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41375-020-01063-7","article-title":"CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia","volume":"35","author":"Sivina","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2024.112735_b0105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105822118","article-title":"Single-cell profiling reveals the importance of CXCL13\/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma","volume":"118","author":"Aoki","year":"2021","journal-title":"Proc. Natl. Acad Sci. U S a."},{"key":"10.1016\/j.intimp.2024.112735_b0110","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/bloodadvances.2020001468","article-title":"Unexpected enhancement of FVIII immunogenicity by endothelial expression in lentivirus-transduced and transgenic mice","volume":"4","author":"Shi","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.intimp.2024.112735_b0115","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2015-08-662916","article-title":"The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity","volume":"127","author":"Chen","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112735_b0120","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/jth.13800","article-title":"Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated","volume":"15","author":"Chen","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2024.112735_b0125","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/j.1538-7836.2003.00534.x","article-title":"Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII","volume":"1","author":"Wilcox","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2024.112735_b0130","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.4049\/jimmunol.163.12.6479","article-title":"Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy","volume":"163","author":"Johnson","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0135","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/bloodadvances.2019000650","article-title":"Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice","volume":"3","author":"Jing","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.intimp.2024.112735_b0140","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/bloodadvances.2017009209","article-title":"The impact of von Willebrand factor on factor VIII memory immune responses","volume":"1","author":"Chen","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.intimp.2024.112735_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.607755","article-title":"Doxorubicin\/nucleophosmin binding protein-conjugated nanoparticle enhances anti-leukemia activity in acute lymphoblastic leukemia cells in vitro and in vivo","volume":"12","author":"Gan","year":"2021","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.intimp.2024.112735_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113780","article-title":"Emodin derivative E35 and its combination with autophagy inhibitor against acute myeloid leukemia cells in vitro and in vivo","volume":"432","author":"Zhang","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2024.112735_b0155","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142906","article-title":"B cell-activating factor modulates the factor VIII immune response in hemophilia A","volume":"131","author":"Doshi","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112735_b0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2018.05.027","article-title":"Risk factors for inhibitor development in severe hemophilia a","volume":"168","author":"Garagiola","year":"2018","journal-title":"Thromb Res."},{"key":"10.1016\/j.intimp.2024.112735_b0165","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2009.03571.x","article-title":"Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A","volume":"7","author":"Navarrete","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl 3","key":"10.1016\/j.intimp.2024.112735_b0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hae.13445","article-title":"Immune tolerance induction: What have we learned over time?","volume":"24","author":"Brackmann","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.intimp.2024.112735_b0175","doi-asserted-by":"crossref","first-page":"1373269","DOI":"10.3389\/fimmu.2024.1373269","article-title":"Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma","volume":"15","author":"Nylund","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2016.01.005","article-title":"Strategies to target long-lived plasma cells for treating hemophilia A inhibitors","volume":"301","author":"Liu","year":"2016","journal-title":"Cell Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0185","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1538-7836.2009.03332.x","article-title":"Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort","volume":"7","author":"Collins","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2024.112735_b0190","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/bjh.12829","article-title":"Inhibitor eradication with rituximab in haemophilia: where do we stand?","volume":"165","author":"Franchini","year":"2014","journal-title":"Br J. Haematol."},{"key":"10.1016\/j.intimp.2024.112735_b0195","first-page":"290","article-title":"Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells","volume":"142","author":"Kaczmarek","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112735_b0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40164-021-00214-5","article-title":"Platelet desialylation and TFH cells-the novel pathway of immune thrombocytopenia","volume":"10","author":"Chen","year":"2021","journal-title":"Exp. Hematol Oncol."},{"key":"10.1016\/j.intimp.2024.112735_b0205","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1038\/s41467-024-47691-w","article-title":"PD-L1- and IL-4-expressing basophils promote pathogenic accumulation of T follicular helper cells in lupus","volume":"15","author":"Tchen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.112735_b0210","doi-asserted-by":"crossref","first-page":"14030-","DOI":"10.1038\/mtm.2014.30","article-title":"Ex vivo expanded autologous polyclonal regulatory T Cells suppress inhibitor formation in hemophilia","volume":"1","author":"Sarkar","year":"2014","journal-title":"Mol Ther Methods Clin Dev."},{"key":"10.1016\/j.intimp.2024.112735_b0215","first-page":"23","article-title":"Cellular therapeutics and immunotherapies in wound healing - on the pulse of time?","volume":"11","author":"Huelsboemer","year":"2024","journal-title":"Mil Med Res."},{"key":"10.1016\/j.intimp.2024.112735_b0220","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fimmu.2015.00030","article-title":"Distinct transcriptomic features are associated with transitional and mature B-Cell populations in the mouse spleen","volume":"6","author":"Kleiman","year":"2015","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0230","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4049\/jimmunol.174.2.817","article-title":"Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy","volume":"174","author":"Gong","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0235","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal Centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52473","article-title":"Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination","volume":"9","author":"Stebegg","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2024.112735_b0245","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","article-title":"Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A","volume":"130","author":"Zerra","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112735_b0250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0255","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clim.2018.08.003","article-title":"Induction of plasmablasts by follicular helper T cell-CXCL13 axis upon occurrence of herpes zoster","volume":"195","author":"Fukuchi","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0260","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/a-2071-0477","article-title":"Activation of the acute-phase response in hemophilia","volume":"123","author":"Knowles","year":"2023","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.intimp.2024.112735_b0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2017.11.003","article-title":"Cytokines in the pathogenesis of hemophilic arthropathy","volume":"39","author":"Wojdasiewicz","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2024.112735_b0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0275","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood-2007-09-110874","article-title":"TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts","volume":"111","author":"Bossen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112735_b0280","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3389\/fimmu.2018.02285","article-title":"BAFF and BAFF-Receptor in B Cell selection and survival","volume":"9","author":"Smulski","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0285","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3389\/fimmu.2018.00687","article-title":"G\u03b1(i) signaling promotes marginal Zone B Cell development by enabling transitional B Cell ADAM10 expression","volume":"9","author":"Hwang","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112735_b0290","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cytogfr.2013.12.011","article-title":"The function of BAFF on T helper cells in autoimmunity","volume":"25","author":"Chen","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2024.112735_b0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1084\/jem.20130505","article-title":"Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation","volume":"211","author":"Goenka","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112735_b0300","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(01)00130-3","article-title":"Regulation of the T-independent humoral response by TACI","volume":"14","author":"von Bulow","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112735_b0305","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2024.112735_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110583","article-title":"Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells","volume":"38","author":"Smulski","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2024.112735_b0315","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.4049\/jimmunol.180.6.3655","article-title":"Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL","volume":"180","author":"Benson","year":"2008","journal-title":"J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T08:08:32Z","timestamp":1732954112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924012566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":63,"alternative-id":["S1567576924012566"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112735","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-mCD20 in combination with \u03b1-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia A mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112735"}}